Astute Medical Logo
Innovative biomarkers.  Smarter healthcare.

The NephroCheck®  Test for AKI Risk Assessment

A single-use cartridge designed to detect biomarkers of acute kidney injury (AKI), TIMP-2 and IGFBP-7, the NephroCheck® Test System provides results in 20 minutes.

NephroCheck® Test Procedure

The test procedure involves the operator applying a fresh or thawed (i.e. previously frozen) clinical urine sample (mixed with labeled fluorescent conjugate) to the NephroCheck® Test Cartridge, and then inserting the test cartridge into the Astute140® Meter for incubation, reading, result calculation, and result display.

Intended Use

The Astute Medical NephroCheck® Test System is intended to be used in conjunction with clinical evaluation in patients who currently have or have had within the past 24 hours acute cardiovascular and or respiratory compromise and are ICU patients as an aid in the risk assessment for moderate or severe acute kidney injury (AKI) within 12 hours of patient assessment. The NephroCheck® Test System is intended to be used in patients 21 years of age or older.

The NephroCheck® Test and the Astute140® Meter are CE marked. 

Find out more about the NephroCheck® Test and view the Package Insert.

Revolutionary biomarkers in human acute kidney injury: TIMP-2 and IGFBP-7

©2020 Astute Medical, Inc. Astute Medical®, the AM logo, Astute140®NephroCheck®, the NephroCheck® logo, and AKIRisk® are registered trademarks of Astute Medical, Inc. in the United States. For information regarding trademarks and other intellectual property applicable to this product, including international trademarks, please see PN 0231 Rev G 2019/02/12